Peijia Medical Ltd. ( (HK:9996) ) has issued an announcement.
Peijia Medical Ltd. has announced that its Board of Directors will convene on March 25, 2025, to review and approve the company’s annual financial results for the year ending December 31, 2024. The meeting will also consider the recommendation for the payment of a final dividend, highlighting the company’s ongoing commitment to shareholder value and financial transparency.
More about Peijia Medical Ltd.
Peijia Medical Ltd. is a company incorporated in the Cayman Islands, operating within the medical industry. It focuses on developing and providing medical solutions, with a particular emphasis on innovative healthcare products and services.
YTD Price Performance: 9.38%
Average Trading Volume: 1,018
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €374.7M
Learn more about 9996 stock on TipRanks’ Stock Analysis page.